Literature DB >> 35426856

Cutaneous Ewing Sarcoma Presenting as a Second Primary Malignancy in a Child.

Jessica Daley1, Nathan Williams2, Claudia M Salgado3, Charles Schultz4, Julia Meade1, John Ozolek4, Brock Lindsey3, Kelly M Bailey1.   

Abstract

Ewing sarcoma is an EWS-ETS family member-driven malignancy that most commonly arises from bone. Cutaneous Ewing sarcoma is a rare variant which harbors an EWS-ETS family fusion but demonstrates an immunohistochemical staining pattern distinct from classic Ewing tumors. EWSR1 fluorescence in situ hybridization testing interpretation can be challenging in the setting of cutaneous Ewing sarcoma, making an integrated histologic and sequencing approach key for an accurate diagnosis. Here, we report a pediatric patient with a history of neuroblastoma treated with surgery only that developed a cutaneous nodule and was diagnosed with cutaneous Ewing sarcoma as a second primary cancer.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2022        PMID: 35426856      PMCID: PMC9562594          DOI: 10.1097/MPH.0000000000002457

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.170


  22 in total

1.  Primary Cutaneous Ewing Sarcoma With Ewsr1-Erg Fusion.

Authors:  Ana M Molina-Ruiz; Klaus J Busam
Journal:  J Cutan Pathol       Date:  2016-09       Impact factor: 1.587

2.  EWSR1 fusions: Ewing sarcoma and beyond.

Authors:  Vickie Y Jo
Journal:  Cancer Cytopathol       Date:  2020-01-29       Impact factor: 5.284

Review 3.  Primary cutaneous Ewing sarcoma: a systematic review focused on treatment and outcome.

Authors:  M Delaplace; C Lhommet; G de Pinieux; B Vergier; A de Muret; L Machet
Journal:  Br J Dermatol       Date:  2012-03-05       Impact factor: 9.302

4.  Clinical features and outcomes in patients with secondary Ewing sarcoma.

Authors:  Mark A Applebaum; Robert Goldsby; John Neuhaus; Steven G DuBois
Journal:  Pediatr Blood Cancer       Date:  2012-07-27       Impact factor: 3.167

5.  Superficial primitive Ewing's sarcoma: a clinicopathologic and molecular cytogenetic analysis of 14 cases.

Authors:  Marie J Terrier-Lacombe; Louis Guillou; Frédéric Chibon; Gabrielle Gallagher; Jean Benhattar; Philippe Terrier; Dominique Ranchère; Jean-Michel Coindre
Journal:  Mod Pathol       Date:  2008-09-26       Impact factor: 7.842

Review 6.  Voluntary Second Opinions in Pediatric Bone and Soft Tissue Pathology: A Retrospective Review of 1601 Cases From a Single Mesenchymal Tumor Consultation Service.

Authors:  Alyaa Al-Ibraheemi; Andrew L Folpe
Journal:  Int J Surg Pathol       Date:  2016-06-29       Impact factor: 1.271

7.  Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma.

Authors:  Steven G DuBois; Mark D Krailo; Allen Buxton; Stephen L Lessnick; Lisa A Teot; Dinesh Rakheja; Brian D Crompton; Katherine A Janeway; Richard G Gorlick; Julia Glade-Bender
Journal:  Arch Pathol Lab Med       Date:  2021-12-01       Impact factor: 5.686

8.  Cutaneous Ewing's sarcoma secondary to chemotherapy given for testis tumor: Case report.

Authors:  Serhat Tanık; Kürşad Zengin; Sebahattin Albayrak; Recep Eryılmaz; Deniz Yılmaz; Necip Pirinçci
Journal:  Int J Surg Case Rep       Date:  2014-10-22

9.  Ewing's Sarcoma as a Second Malignancy in Long-Term Survivors of Childhood Hematologic Malignancies.

Authors:  Fabian Wolpert; Michael A Grotzer; Felix Niggli; Dieter Zimmermann; Elisabeth Rushing; Beata Bode-Lesniewska
Journal:  Sarcoma       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.